452 related articles for article (PubMed ID: 7690782)
21. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
[TBL] [Abstract][Full Text] [Related]
22. Testing for HCV markers.
Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
Vardas E; Sitas F; Seidel K; Casteling A; Sim J
Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
[TBL] [Abstract][Full Text] [Related]
25. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
[TBL] [Abstract][Full Text] [Related]
26. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
[TBL] [Abstract][Full Text] [Related]
27. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
[TBL] [Abstract][Full Text] [Related]
28. Antigenic heterogeneity of the NS3 proteins in hepatitis C virus genotypes 1 and 6.
Qiao W; Xie P; Cai B; Li L
Intervirology; 2011 Feb; 54(2):53-60. PubMed ID: 20829600
[TBL] [Abstract][Full Text] [Related]
29. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.
Schupper H; Hayashi P; Scheffel J; Aceituno S; Paglieroni T; Holland PV; Zeldis JB
Hepatology; 1993 Nov; 18(5):1055-60. PubMed ID: 7693570
[TBL] [Abstract][Full Text] [Related]
30. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus.
Beard MR; Abell G; Honda M; Carroll A; Gartland M; Clarke B; Suzuki K; Lanford R; Sangar DV; Lemon SM
Hepatology; 1999 Jul; 30(1):316-24. PubMed ID: 10385673
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning of the immunodominant regions of hepatitis C virus type III and IV by immunoscreening.
Sato A; Kazami J; Arima T; Nakamura H; Kunitomo T
Acta Virol; 1993; 37(2-3):132-42. PubMed ID: 7692715
[TBL] [Abstract][Full Text] [Related]
32. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
[TBL] [Abstract][Full Text] [Related]
33. Type-specific antibody for hepatitis C virus detected by use of NS-4 peptide and hepatitis C virus genome in Korea.
Son HC; Yoon MS; Kim YJ; Kim IH; Kim YS
Rinsho Byori; 2002 May; 50(5):533-40. PubMed ID: 12078055
[TBL] [Abstract][Full Text] [Related]
34. Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays.
Prescott LE; Berger A; Pawlotsky JM; Conjeevaram P; Pike I; Simmonds P
J Med Virol; 1997 Nov; 53(3):237-44. PubMed ID: 9365889
[TBL] [Abstract][Full Text] [Related]
35. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
[TBL] [Abstract][Full Text] [Related]
36. [Specific antibody assay for genotyping of hepatitis C virus].
Kohara M
Nihon Rinsho; 1994 Jul; 52(7):1728-33. PubMed ID: 7521411
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of N-14 antibody (ELISA) in diagnosis of non-A, non-B liver disease].
Yone Y
Fukuoka Igaku Zasshi; 1992 Apr; 83(4):156-67. PubMed ID: 1318860
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
[TBL] [Abstract][Full Text] [Related]
39. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in northern Estonia.
Tallo T; Lappalainen M; Tefanova V; Priimägi I
Acta Virol; 2000; 44(3):175-8. PubMed ID: 11155361
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]